Influenza: Molecular Virology | Book
Caister Academic Press
and Yizhi Jane Tao2
1Dept Biochemistry and Molecular Biology, Baylor College of Medicine, Texas, USA; 2Dept Biochemistry and Cell Biology, Rice University, Houston, USA
February 2010 Available now!
GB £159 or US $319 (hardback).
x + 196
How to Order
. Library recommendation form
In the last 100 years there have been three major influenza pandemics: Spanish Flu in 1918, Asian Flu in 1957 and Hong Kong Flu in 1968. These claimed the lives of approximately 50 million, 2 million and 1 million people respectively. Added to this is the annual death toll of 250,000 to 500,000 people worldwide with a further 3 to 4 million people suffering severe illness. These statistics make influenza an extremely important pathogen. In 1997 the alarming emergence of a new, highly pathogenic subtype, H5N1, which has a 50% mortality rate, provided a major impetus for renewed influenza research. However the battle against influenza is going to be difficult. Recently another subtype, H1N1, has emerged. This subtype causes a relatively mild infection in humans, however is highly transmittable between people and a new influenza pandemic was declared by the World Health Organization. If this virus were to acquire some of the lethal capabilities of H5N1, then the ensuing pandemic could be devastating.
In this timely book, internationally renowned scientists critically review the current research and the most important discoveries in this highly topical field. Subjects covered include the NS1 protein of influenza A virus, the structure of influenza NS1, influenza B hemagglutinin, influenza A nucleoprotein, influenza A hemagglutinin glycoproteins, the M2 channel, virulence genes of the 1918 pandemic influenza, influenza virus polymerase, gene diagnostic microarrays, and computer-assisted vaccine design.
Highly informative and well referenced, this book is essential reading for all influenza specialists and is recommended reading for all virologists, immunologists, molecular biologists, public health scientists and research scientists in pharmaceutical companies.
"This is a good quality, concise book on the basic nature of influenza viruses that comprehensively covers the current work on influenza." from Doodys
"a series of excellent and high-powered articles ... an up-to-date review of the advancements in molecular influenza virology ... of interest to a range of readers including post-graduate and basic science researchers, virologists and those involved with drug design and development." from Iain Stephenson (Leicester Royal Infirmary, Leicester, UK) writing in Expert Rev. Vaccines (2010) 9: 719-720.
"I particularly enjoyed a very thorough account of the influenza A haemagglutinin ... it's a nicely put together book that summarizes recent developments on the structural side of influenza replication. Appropriate audiences for the book would be final-year virology students and influenza researchers." from Paul Digard (University of Cambridge, UK) writing in Microbiol. Today (2010)
"good quality, concise book ... comprehensively covers the current work on influenza" (Doodys); "a series of excellent and high-powered articles" (Expert Rev. Vaccines); "a nicely put together book" (Microbiol. Today)
The NS1 Protein of Influenza A Virus
Chen Zhao, Rei-Lin Kuo and Robert M. Krug
The NS1 protein of influenza A viruses is a small (230-237-amino acid), multi-functional dimeric protein that participates in both protein-RNA and protein-protein interactions. It is comprised of two functional domains: N-terminal (amino acids 1-73) RNA-binding domain; and C-terminal (amino acids 74-230/237) effector domain. Here we focus on several of the best-characterized functional interactions of the NS1 protein. A major role of the NS1 protein is to counter host cell antiviral responses. Thus, the RNA-binding domain binds double-stranded (ds) RNA, thereby inhibiting the dsRNA activation of the antiviral oligo A synthetase/RNase L pathway that is induced by interferon-α/β (IFN-α/β). A region of the effector domain binds the protein kinase PKR, thereby preventing its activation that would otherwise lead to the shutdown of both viral and host protein synthesis. Another region of the effector domain binds the 30 kDa subunit of the cleavage and polyadenylation specificity factor (CPSF30), a cellular protein required for the 3' end processing of all cellular pre-mRNAs. As a consequence, the substantial amount of IFN-β pre-mRNA that is synthesized in virus-infected cells is not processed to form mature IFN-β mRNA, thereby suppressing the IFN response. The NS1 protein also has other functions that are not directly involved in countering host antiviral responses. The effector domain of the NS1 protein binds the P85β regulatory subunit of phosphoinositide 3-kinase (PI3K), resulting in the activation of PI3K and the Akt kinase, which in turn inhibits apoptosis. The C-termini of pathogenic influenza A viruses have a PDZ-binding motif that has been implicated in pathogenicity. The NS1 protein also interacts with the cellular nuclear export protein (TAP), and may have a role in the nuclear export of viral mRNAs. Finally, the NS1 protein functionally interacts with the viral polymerase complex in infected cells and likely has a role in the regulation of viral RNA synthesis.
Structural Insights into the Function of Influenza NS1
Zachary A. Bornholdt, Berenice Carrillo and B.V. Venkataram Prasad
The non-structural protein 1 (NS1) of influenza virus is a potent antagonist of the cellular antiviral interferon (IFN) response. It is a multifunctional protein with two domains, a dsRNA binding domain (RBD) and an effector domain (ED) which interacts with various cellular proteins. Although, initially sequestration of dsRNA was considered the primary mechanism for countering IFN, subsequent studies have shown that the interactions of ED with various cellular proteins are likely involved. NS1 is shown to be a virulence determinant, especially in the highly pathogenic H5N1 viruses that are currently a threat for another influenza pandemic. Among various influenza virus strains, NS1 is relatively well conserved with major differences occurring in the linker region and the C-terminus, where several NS1 proteins contain truncations. How these differences contribute to virulence remains unknown but these differences seem to have an effect on NS1 function that may be strain specific. In recent years, substantial progress has been made toward understanding of the structural aspects of this two-domain protein. Here we review this progress and discuss the structural basis of various activities of NS1.
Influenza Type B Virus Hemagglutinin: Antigenicity, Receptor binding and Membrane Fusion
Influenza B virus infection remains a significant cause of morbidity and mortality worldwide, with particularly severe impacts on the young and the elderly. However, compared to influenza A virus, influenza B virus was very poorly studied. Most recently, a series of research have been published that drastically deepened our understanding of influenza B virus. In this review, I will summarize the recent advances on influenza B virus hemagglutinin from aspects of antigenicity, receptor binding and membrane fusion. In addition, I will discuss some of the remaining challenges in influenza B virology.
Influenza A Virus Nucleoprotein
Yizhi Jane Tao and Qiaozhen Ye
The (-) RNA genome of the influenza A virus, eight segments in total, is encapsidated in the form of ribonucleoprotein (RNP) complexes. The nucleoprotein (NP), the major protein component of RNPs, binds along the entire length of each genomic RNA segment at a 24-nt interval, forming the double-helical RNP structures found in mature viruses. The viral polymerase, consisting of PA, PB1, and PB2 subunits, binds to the two RNA termini of the RNP. As one of the most abundant proteins made in infected cells, influenza virus NP has essential roles in many important viral processes, including intracellular trafficking of the viral genome, viral RNA replication, viral genome packaging, and virus assembly. The recently determined crystal structures of two NP trimers show an overall fold and an external RNA binding mode that are different from rhabdovirus NP, as confirmed by a new cryo-EM reconstruction of a mini-RNP. Site-directed mutagenesis and RNA binding assays have confirmed that a positively charged groove plays an important role in NP:RNA binding. Other exciting results from recent studies of NP oligomerization, NP RNA binding, NP intracellular trafficking, NP phosphorylation, and NP-supported viral RNA replication are also discussed. These new findings have led to a more detailed model for RNP structure and assembly.
Influenza A Virus Hemagglutinin Glycoproteins
David A. Steinhauer
The influenza A virus hemagglutinin glycoprotein (HA) is the principle mediator of viral entry into host cells. It is responsible for attachment of virions to sialic acid-containing receptors on the host cell surface, and for inducing membrane fusion between viral envelopes and cellular endosomal membranes following endocytosis. HA serves a classic example of a type I membrane glycoprotein, with a cleaved N-terminal signal sequence, a membrane anchor domain near the C-terminus, and post-translational modifications resulting from the addition of N-linked oligosaccharide side chains to the ectodomain, and acylation of cysteine residues in the cytoplasmic tail region. HA spikes on the viral surface are also the major target for neutralizing antibodies, and as such, the antigenic properties of the HA are of fundamental significance for the design of influenza vaccines. The depth of knowledge relating to high resolution atomic structures of HA in various forms have made it a prototype for the investigation of viral glycoproteins in general, and this chapter outlines some of the special features that have derived from structure-function studies on HA.
Structure and Mechanism of the M2 Channel
James J. Chou and Jason R. Schnell
Viral ion channels have minimalist architecture. Despite their relatively simple structure, viral channels can achieve highly specific gating and selection of ions, and the particular mechanisms appear to be different from those of prokaryotes and eukaryotes. The unique structural and functional properties of viral channels make them ideal targets for antiviral therapy because the molecules that inhibit viral ion channels may not interact with human ion channels. The M2 proton channel of influenza A virus is a model viral ion channel. This small channel, whose pore is formed by four equivalent transmembrane helices, is the target of two widely used anti-influenza A drugs, amantadine and rimantadine, both belonging to the adamantane class of compounds. However, resistance of influenza A to adamantane is now widespread. Naturally-occurring resistants mutants have been observed in as many as six different positions in the transmembrane segment of M2. How could there be so many different resistance-conferring mutations along a transmembrane helix of 25 amino acids? The recently-determined high-resolution structures of M2 in complex with adamantane allow us to begin answering this question.
Virulence Genes of the 1918 Pandemic Influenza Virus
Natalie Pica, Terrence M. Tumpey, Adolfo García-Sastre and Peter Palese
The pandemic influenza virus of 1918 was extremely virulent and caused significant morbidity and mortality to millions of people worldwide. The extinct virus caused severe pathology in both the upper and lower respiratory tract, resulting in fatal respiratory complications and bacterial pneumonia. The pathology associated with 1918 influenza virus infections is thought to be the result of the exposure of an immunologically na•ve host population to an unusually virulent virus. Using reverse genetics, the 1918 pandemic virus has been studied in different animal models in an attempt to determine which viral genes contribute to the increased virulence. Studies to date point to the role of the hemagglutinin, neuraminidase, and the polymerase basic protein 1 genes as the virulence genes responsible for the high pathogenicity seen with the 1918 influenza virus.
Polymerase Structure and Function
Mark Bartlam, Zhiyong Lou, Yingfang Liu and Zihe Rao
The influenza virus RNA-dependent RNA polymerase is a heterotrimeric complex (PA, PB1 and PB2) with multiple enzymatic activities for catalyzing viral RNA transcription and replication. Its critical roles in the influenza virus life cycle and high sequence conservation suggest it should be a major target for therapeutic intervention. However, until very recently, functional studies and drug discovery targeting the influenza polymerase have been hampered by the lack of three-dimensional structural information. In this chapter, we will review the recent progress in the structure and function of the influenza polymerase, and discuss prospects for the development of anti-influenza therapeutics.
MChip: A Single Gene Diagnostic Microarray for Influenza A
Erica D. Dawson and Kathy L. Rowlen
Rapid and accurate diagnostic methods for typing and subtyping influenza viruses are needed for improved worldwide surveillance. Although molecular-based diagnostic methods are becoming more widespread in influenza diagnosis, they generally involve amplification of the hemagglutinin (HA) and/or neuraminidase (NA) gene segments for subtyping. We have developed a low-density microarray (MChip) and accompanying pattern recognition algorithm combined with a reverse transcription PCR based assay and that allows for the identification and subtyping of influenza A viruses in approximately seven hours. MChip is unique in that it is based solely on the matrix (M) gene segment which has enough genetic diversity for subtype analysis but sufficient genetic stability to circumvent the need for continual redesign of primers and microarray probes. An overview is presented here of several MChip studies undertaken over the last several years, highlighting the ability of MChip to identify and subtype influenza A/H1N1, H3N2, and H5N1 viruses. In addition, we present data indicating that the MChip performs well relative to gold standard methods for identification of influenza A. It is our hope that improved diagnostic assays coupled with improvements in microarray detection methodology will enable better worldwide surveillance and diagnosis of influenza viral infections.
Computer-assisted Vaccine Design
Hao Zhou, Ramdas S. Pophale and Michael W. Deem
We define a new parameter to quantify the antigenic distance between two H3N2 influenza strains: we use this parameter to measure antigenic distance between circulating H3N2 strains and the closest vaccine component of the influenza vaccine. For the data between 1971 and 2004, the measure of antigenic distance correlates better with efficacy in humans of the H3N2 influenza A annual vaccine than do current state of the art measures of antigenic distance such as phylogenetic sequence analysis or ferret antisera inhibition assays. We suggest that this measure of antigenic distance could be used to guide the design of the annual flu vaccine. We combine the measure of antigenic distance with a multiple-strain avian influenza transmission model to study the threat of simultaneous introduction of multiple avian influenza strains. For H3N2 influenza, the model is validated against observed viral fixation rates and epidemic progression rates from the World Health Organization FluNet - Global Influenza Surveillance Network. We find that a multiple-component avian influenza vaccine is helpful to control a simultaneous multiple introduction of bird-flu strains. We introduce Population at Risk (PaR) to quantify the risk of a flu pandemic, and calculate by this metric the improvement that a multiple vaccine offers.
How to buy this book
(EAN: 9781904455578 Subjects: [virology] [microbiology] [medical microbiology] [molecular microbiology])